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ABSTRACT
Mechanisms and Signal Transduction Pathways Involved in Bovine Oocyte Activation 
by
Ammon Hanson Bayles, Doctor of Philosophy
Utah State University, 2012
Major Professor: Dr. Kenneth L. White
Department: Animal, Dairy, and Veterinary Sciences
 In addition to contributing genes at fertilization, the sperm cell induces the oocyte 
to leave its arrested state and resume metabolism in the process of activation.  A hallmark 
of oocyte activation is a release of intracellular calcium (Ca2+i) from the endoplasmic 
reticulum. The mediators of oocyte activation have been studied in many animal models, 
while little is known in the bovine model. Both Src Family Kinase (SFK) and 
Phospholipase C (PLC) enzymes have been reported to be involved in oocyte activation 
in other animal models. In this dissertation are described experiments that define the role 
of SFK and PLC enzymes in the pathway leading to Ca2+i and calcium induced calcium 
release in bovine oocyte activation. Western blotting was used to discover that SFKs Src, 
Hck, and Lck are present in matured bovine oocytes, and Src, Blk, and Yes are present in 
acrosome reacted bovine spermatozoa. The PLC δ1 and δ3 are present in both matured 
bovine oocytes and spermatozoa. PLC δ4, γ2, and η2 are present in matured bovine 
oocytes.  Microinjecting a known general SFK inhibitor, PP2, significantly decreases 
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both Ca2+i and cleavage rates. Microinjecting a 13 amino acid peptide that mimics the 
phosphorylated carboxyl terminal region of pp60c-src decreases both Ca2+i and cleavage 
rates. Microinjecting a downstream substrate of pp60c-src sequestered any signal 
produced by Src and decreased Ca2+i and cleavage rates. Microinjecting primary 
antibodies raised against PLC isotypes blocked both Ca2+i and cleavage rates, giving 
insight to the mechanism of calcium induced calcium release in the bovine model. The 
PLC isotypes δ3, δ4, and γ2 decreased Ca2+i oscillations and cleavage rates, indicating 
they are involved in both IP3R and RyR activation. PLC δ4 and η2 did not impact Ca2+i 
but did significantly decrease cleavage rates. The data presented in this dissertation 
increase the understanding of the pathway leading to bovine oocyte activation and further 
confirm that the detailed pathway differs among animal models. 
          (125 pages)
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PUBLIC ABSTRACT
Mechanisms and Signal Transduction Pathways Involved in Bovine Oocyte Activation 
by
Ammon Hanson Bayles, Doctor of Philosophy
Utah State University, 2012
Major Professor: Dr. Kenneth L. White
Department: Animal, Dairy, and Veterinary Sciences
 Being able to create a genetically identical, living replicate of a prized animal 
sounds impossible. Through advanced scientific methods and the wonders of mother 
nature it can be accomplished by a process called cloning. In 2003, the USU Animal, 
Dairy, and Veterinary Science department and Dr. Kenneth L. White gained world wide 
recognition when they, along with a team for Idaho, cloned the first equine species. 
 Cloning certain animals could be very advantageous to the agricultural industry. 
Prized animals that have died could be cloned, producing the best meat and milk supply. 
Animals that are sterile or endangered can be cloned, restoring the genetics and 
population. Although there are benefits to cloning there are also drawbacks. One of the 
biggest hurdles is the success rate. Cloning works correctly less than 8% of the time. 
Methods that are not biological must be used to produce a clone, and these harsh methods 
could cause a decrease in success. If there was a better, more biological way to produce a 
clone the success rate would improve.  
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 Through funding provided by the National Institute of Food and Agriculture, U.S. 
Department of Agriculture, under Agreement No. 08-34526-19199 and 09-34526-19808, 
ways to improve the methods of producing a clone have been studied. This dissertation 
outlines a couple pathways to possibly improving cloning. The biology that takes place is 
complex and many additional studies will need to be conducted before some significant 
improvements are made. 
 If the success of cloning improves, there may come a time when these methods 
are used to improve human health by producing human tissue and organs that are 
genetically perfect. The possibility of curing life threatening illness through therapeutic 
cloning is exciting. As the success rate of cloning animals improves, so does the chance 
that cloning will affect and improve human lives. 
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CHAPTER 1
REVIEW OF LITERATURE 
 Bovine oocytes are ovulated at an immature state of metabolic arrest at metaphase 
II (MII). In order for the oocyte to exit this it must undergo oocyte activation. The 
biochemical pathway leading to oocyte activation has been studied extensively in animal 
models such as sea urchin, zebrafish, ascidian, starfish, Xenopus, and murine models. To 
date, there is very little data available explaining the pathways seen in bovine oocyte 
activation. 
Oocyte Activation: An Overview
 Oocyte activation is a term given to a set of critical events that takes place when 
sperm and egg unite. It is initiated by the fertilizing sperm and is essential for proper 
embryonic development. The defining feature of oocyte activation is intercellular calcium 
(Ca2+i) release from the endoplasmic reticulum (ER) (reviewed by Whitaker [1]). Other 
features of oocyte activation include cortical granule exocytosis, resumption and 
completion of meiosis II, second polar body extrusion, pronuclear formation, and DNA 
synthesis [2]. Some of the events associated with of oocyte activation begin within 
seconds of sperm-egg binding, while others last for hours after binding [3]. The rise and 
fall of Ca2+i lasts up to several hours in mammalian species [4-6]. One early event in 
mammalian oocyte activation is the exocytosis of cortical granuals. Ca2+i release plays an 
important role in this process. Cortical granuals are located along the cortical region of 
the oocyte vitelline membrane [7] and contain enzymes that can modify the zona 
pellucida (ZP) [8, 9]. Modifications to the ZP are an important mechanism that provide a 
block to polyspermy [1, 10-14].  
 The increase of Ca2+i also plays an important role in the resumption of meiosis II. 
Bovine oocytes are arrested at MII at ovulation, due to the presence of maturation 
promoting factor (MPF) [15]. MPF remains active when cytosolic factor cyclin B1 is 
present. The increase in Ca2+i shortly after sperm-oocyte binding induces cyclin 
degradation, which leads to a down regulation of MPF [16]. A decrease in MPF prompts 
the oocyte to reenter the cell cycle, thus leaving MII arrest. The extrusion of the second 
polar body is a distinct morphological change that occurs during the resumption of 
meiosis. Upon extrusion of the second polar body, the DNA from the oocyte becomes 
haploid [17]. Several hours after sperm-oocyte binding, Ca2+i transients cease, the 
pronuclei form, and DNA synthesis is initiated [18]. 
Mechanisms of Oocyte Activation 
 The signal transduction pathway leading to oocyte activation has been described 
by two competing theories, a receptor mediated pathway and soluble sperm-borne 
oocyte-activating factor [19]. The receptor mediated hypotheses postulates that as sperm 
undergo the acrosome reaction, ligands on the inner acrosomal membrane are exposed. 
Following zona pellucida penetration and migration across the peri-vitelline space, these 
inner acrosomal sperm ligands are available to bind to receptors located on the vitelline 
membrane. There have been several proposed sperm ligands, including, disintegrins 
[20-22], fertilin [23, 24], Izumo [25, 26], cyritestin [27], and GPI-anchored proteins [28, 
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29].  All have been shown to play a role in fertilization. In addition, there are likely 
oocyte receptors on the oocyte that include, integrins [21, 22, 30-33] and tetraspannins 
[34] which function in synchrony with integrins. There are two other likely candidate 
receptors on the oocyte. G-protein coupled receptors and/or receptor tyrosine kinase. 
These two are potential candidates due to their downstream effects. Integrins, G-protein 
coupled receptors and receptor tyrosine kinase are all known to influence downstream Src 
Family Kinases (SFK) and/or Phospholipase C (PLC) family enzymes. These cell surface 
receptors activate Phopholipase C (PLC), which cleaves phosphotidylinsoitol 4,5-
bisphosphate (PIP2), producing membrane-bound diacyglycerol (DAG) and cytosolic 
soluble 1,4,5-inositol trisphosphate (IP3). The binding of IP3 to the IP3 receptor (IP3R) 
on the endoplasmic reticulum leads to the release of Ca2+i within the cytosol of the oocyte 
[35, 36].
 The second theory states that a sperm-borne oocyte activating factor (SOAF) is 
responsible for oocyte activation [37]. This theory follows the logic that as the sperm’s 
inner acrosomal membrane fuses with the oocyte vitelline membrane, a soluble protein is 
released into the oocyte’s cytoplasm and is free to act as a SOAF. There have been 
multiple reports that indicate PLC ζ is the SOAF [38-43] and that in murine oocytes PLC 
β1 may work along side[44]. Once in the oocyte cytoplasm, SOAF could act on cytosolic 
proteins such as PIP2, PI3 kinase, PLC, and/or SFK to initiate Ca2+i release through IP3R 
activation. It is accepted that Ca2+i comes from stores within the ER of the oocyte 
[45-52]. Ryanodine receptors (RyR) also play a role with IP3R in Ca2+i and calcium-
induced calcium release (CICR). It is accepted that Ca2+i can come from cellular stores 
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through two separate channels, IP3R and RyR [53, 54]. Both IP3R and RyR are involved 
in Ca2+i in many different cell types and have been shown to be involved in sea urchin 
oocyte activation [55]. IP3R and RyR are both present in murine [56-58], porcine [59], 
human [60-62], and bovine [54, 63] oocytes. IP3R appears to be involved in the initial 
Ca2+i release that is seen at the early stages of activation, while the RyR is involved in 
later stages as a CICR mechanism [64]. Both IP3R and RyR are able to produce repetitive 
Ca2+i transients [65-67], and specifically, RyR operating primarily in CICR in bovine 
oocyte activation [54, 63]. Regardless of its source, Ca2+i is a hallmark of oocyte 
activation for all animal models studied to date.
Src Family Kinases 
 This literature review will focus on the history, structure, and activation of Src 
Family Kinases (SFK), and their involvement in oocyte activation in different animal 
models. SFKs are present in almost every animal cell type. They are activated by growth 
factors, cell-cell adhesion, cytokines, and antigen receptors [68, 69]. Src was first 
discovered in 1977 by Burgge and Erikson [70]. Shortly thereafter, it was discovered that 
Src had protein tyrosine kinase activity [71, 72]. There are nine SFK members: Src, Hck, 
Lck, Fyn, Lyn, Blk, Fgr, Yrk, and Yes. All SFKs have very similar structural domains, 
consisting of  SH3, SH2, and tyrosine kinase domains [73]. They also contain an SH4 
membrane-targeting region, located near the N-terminus. This SH4 domain is always 
myristoylated and often palmitoylated [74].
 SFKs participate in oocyte activation in several animal models. Sea urchin, 
ascidian, and starfish share a similar activation pathway involving SFK. Following 
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sperm-oocyte binding and/or fusion, SFK is activated, which then activates downstream 
PLC γ and leads to a release of Ca2+i through IP3R [35, 75, 76]. To date, it is unclear 
which SFK member(s) are involved in these models. Zebrafish use a similar signal 
transduction pathway in which Fyn and Src are both activated prior to PLC γ activation 
[77]. A Src-related protein has been isolated from Xenopus oocytes [78], and it appears 
that SFK activation of PLC γ is required for fertilization [45]. The murine model appears 
quite different from the previously mentioned animal models, as it seems that SFK is not 
involved at fertilization. There are reports that SFK is not required for Ca2+i release and 
oocyte activation [79, 80]. Supposedly it has been shown that female mice lacking the 
SFK Fyn, exhibit a reduction in fertility. This decrease in fertility appears to result from 
cytoskeletal defects and is not due to a reduction in Ca2+i transients [81]. SRC is present 
in pre-acrosome reacted bovine sperm and is involved in the acrosome reaction during 
sperm-zona pellucida binding [82]. It is unknown if other SFKs are involved in the 
acrosome reaction or if they are involved in bovine oocyte activation. 
Phospholipase C 
 Phospholipase C (PLC) is an effector molecule in signal transduction. PLC is 
responsible for the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) to produce 
two second messengers, membrane bound diacylglycerol (DAG) and soluble inositol 
1,4,5-trisphosphate (IP3). PLC was first recognized in 1953 from work done on pigeon 
pancreas [83] and PLC’s role as Ca2+i mobilizer was first described in 1983 [84]. Since 
then, multiple PLC types of different molecular weight, isoelectric points, and calcium 
dependency have been identified. To date, there are six known PLC isotypes, β, γ, δ, ε, ζ, 
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and η, that have been identified in various mammalian tissues. Within each isotype, there 
are potential isozymes, these are β1, β2, β3, β4, γ1, γ2, δ1, δ3, δ4, ε, ζ, η1, and η2 [85]. 
PLC isozymes contain two very consered regions called the catalytic X and Y domains. 
These domains are located between an EF-hand domain and a C2 domain [86]. PLC 
isozymes also contain a PH domain. It has been demonstrated the the PLC δ1 PH domain 
binds PIP2 and promotes the availability of PLC δ1 to the plasma membrane [87]. 
 PLC γ1 has been implicated in sea urchin, ascidian, zebrafish and starfish oocyte 
activation as being responsible for IP3 production and subsequent Ca2+i release [35, 
75-77, 88]. No other PLC isotypes have been implicated in oocyte activation for these 
model systems. Following fertilization in Xenopus, there is an increase in IP3 
concentration that is involved in Ca2+i release [89, 90]. This spike in IP3 is likely due to 
the involvement of one or more PLC isotypes. Conflicting results show that neither 
PLCγ1 nor PLCβ are required for IP3 production [90], while other studies support that 
PLCγ is required [91] and is made active by SFK [92]. To date, it remains unclear if other 
PLC isotypes are involved in the production of IP3 and Ca2+i release in Xenopus. 
 Many studies have been done on the signal transduction pathway active in murine 
oocyte activation. Integrins mediate sperm-oocyte binding [93-101]. Following binding, 
it appears that mice utilize PLC ζ as a SOAF [38, 39, 42, 43]. PLC ζ is proposed to cleave 
PIP2, producing the IP3 that causes Ca2+i release from the ER via IP3R. Another PLC 
isotype, PLC β1, has been proposed to function in synchrony with PLCζ to produce Ca2+i 
transients and oocyte activation through IP3 production [102]. Recently, the involvement 
of PLC ζ in oocyte activation has been called into question. Aarabi et al claim that the 
6
expression profile and localization of PLC ζ within the sperm head do not support its role 
as the SOAF [103]. They state that following ZP penetration, PLC ζ is no longer present 
within the sperm head and thus could not be involved in Ca2+i. 
 In bovine fertilization, the microinjection of bovine PLC ζ cRNA has been shown 
to activate oocytes at a 0.1 µg/µl [104]. More recently, it has been shown that 
microinjecting 0.1 µg/µl of bovine PLC ζ cRNA did not induce Ca2+i transients [105]. The 
completion of additional studies should resolve these disparities. While PLC ζ may be 
involved in the production of murine Ca2+i transients, its role in bovine oocyte activation 
remains unclear. 
Summary
 Mechanisms of oocyte activation are complex and differ among animals models. 
The biochemical pathways have been well defined in sea urchin, zebrafish, ascidian, 
starfish, and Xenopus. There is very little data available explaining the pathways in 
bovine oocyte activation, while considerable data attempts to explain oocyte activation in 
the murine model. Global conclusions about mammalian activation maybe made 
mistakenly from work done in mice. This dissertation aims to better define the signal 
transduction pathway seen at bovine oocyte activation. 
 Oocyte activation is initiated by the fertilizing sperm and is essential for proper 
embryonic development. A hallmark of oocyte activation is the release of Ca2+i  from the 
ER. The IP3R located on the ER are activated by IP3. IP3 and DAG are produced when 
PIP2 is cleaved by PLC. The source of enzymatically active PLC is unknown in the 
bovine model. 
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Impact of the Project
 This dissertation describes experiments that define the role of SFK and PLC 
enzymes in Ca2+i and CICR in bovine oocyte activation. I microinjected antagonists and 
substrates of SFK, antibodies against the isozymes of PLC, and agonist and antagonists 
of IP3R and RYR followed by in vitro fertilization to better describe the pathway leading 
to Ca2+i and development in bovine oocytes. Western blotting was used to identify 
endogenous SFKs and PLC isotypes within bovine gametes. These data increase the 
understanding of the pathway leading to bovine oocyte activation and confirms that the 
detailed pathway of activation differs among animal models.
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CHAPTER 2
 SRC FAMILY KINASE IN 
THE ACTIVATION OF BOVINE OOCYTES
Abstract
 In addition to contributing genes at fertilization, the sperm cell induces the oocyte 
to leave its MII arrested state and resume metabolism in the process of activation.  A 
hallmark of oocyte activation is a release of intracellular calcium stores that results in 
repetitive transients.  The mediators of oocyte activation have been studied extensively in 
sea urchin, zebrafish, ascidian, starfish, Xenopus, and murine models, while much less is 
known in the bovine model. Src Family Kinases (SFKs) has been reported to be involved 
in oocyte activation in many animal models. In this study we investigated the role of 
SFKs in bovine oocyte activation. Western blotting was used to identify endogenous 
SFKs within bovine gametes. Specific SFKs, notably SRC, were then targeted by the 
microinjection of antagonists and substrates to determine the role of individual SFKs on 
intracellular Ca2+ release following fertilization and cleavage rates 48 hours post-
fertilization. SRC was detected in both bovine oocytes and spermatozoa. Inhibition of 
SRC significantly decreased oocyte activation, as assessed by decreased intracellular 
Ca2+ transients and cleavage rates. These data indicate involvement of SFKs, especially 
SRC, in the bovine oocyte activation pathway, which supports our hypothesis that the 
pathways leading to oocyte activation differ among animal models. 
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Introduction
 Bovine oocytes are ovulated in a state of metabolic arrest at metaphase II (MII). 
Activation allows the oocyte to exit this developmental checkpoint. Oocyte activation is 
initiated by the fertilizing sperm and is essential  for initiating embryonic development.  
Activation includes repetitive intracellular calcium (Ca2+i) transients, cortical granule 
exocytosis, resumption and completion of meiosis II, pronuclear formation, second polar 
body extrusion, DNA synthesis, and subsequent embryonic development [1]. Ca2+i 
transients are involved in cortical granule exocytosis, which initiates a block to 
polyspermy [2-7]. Although the additional biological impacts of Ca2+i transients are not 
fully understood, these transients are believed to be the second messenger responsible for 
initiating down-regulatation of  metaphase promoting factor (MPF) activity [8]. This 
directs the oocyte to re-enter the cell cycle and exit metaphase arrest. 
 Two hypotheses have been proposed to explain the signal transduction pathway 
that results in Ca2+i [9]. One is that spermatozoa bind to a receptor on the vitelline 
membrane of the oocyte.  There are three potential receptor candidates: G-protein 
coupled receptors, receptor tyrosine kinases, and/or integrins.  These receptors are 
thought to activate phospholipase C (PLC) either directly or by an indirect pathway that 
involves SFK activation. PLC cleaves phosphtidylinositol 4,5-bisphosphate (PIP2), 
yielding plasma membrane-bound diacylglycerol (DAG) and soluble cytosolic 1,4,5-
inositol trisphosphate (IP3).  IP3 then binds to the endoplasmic reticulum (ER) 
membrane-spanning IP3 receptor (IP3R). IP3R activation results in the releases of 
calcium from the ER into the cytosol of the oocyte. The second hypothesis proposes that 
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when spermatozoa fuse with the vitelline membrane, a sperm-borne oocyte-activating 
factor (SOAF) [10] is released from the sperm into the oocyte. SOAF interacts with 
cytosolic targets, such as PI3 kinase, SFK, and/or PLC isoforms to generate downstream 
Ca2+i transients via the production of IP3. It is generally accepted for animal models that 
calcium released during Ca2+i transients comes from the ER [11-20].  In many fish and 
echinoderm oocytes ryanodine receptors (RyR) are also a substantial trigger for Ca2+ 
release, acting in parallel with IP3R to facilitate calcium efflux and calcium-induced 
calcium release [21-25].  RyR pathways operate within bovine [26] and murine oocytes 
[27].  Whether through IP3R or RyR pathways, Ca2+i is the hallmark of oocyte activation 
for all animal models studied to date.
 Oocyte activation pathways have been studied extensively in sea urchin, 
zebrafish, ascidian, starfish, Xenopus, and murine models, but there is comparatively 
little information available in the bovine model. Sea urchin, ascidian, and starfish share a 
similar oocyte activation pathway following spermatozoa and oocyte plasma membrane 
binding and/or fusion. This involves the activation of a SFK, which in turn activates 
PLCγ. This produces IP3 which leads to Ca2+ release through the ER bound IP3R 
[28-31]. It is not yet clear which member of the Src kinase family is activated in these 
species and whether more SFK than one plays a role in activation. Zebrafish share a 
similar pathway as the spermatozoa activates the SFK Fyn and/or Src prior to PLCγ 
activation [32]. Oocyte activation in Xenopus can be facilitated through contact with 
cathepsin B [33], peptides containing the integrin-binding RGD sequence [34], or the 
disintegrin region of testies-derived cDNA that codes for a metalloprotease/disintegrin 
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termed xMDC16 [35]. It appears that the Xenopus spermatozoa post-acrosomal sheath 
WW domain binding protein is capable of eliciting Ca2+i [36]. Following fertilization in 
Xenopus, there is a rise in IP3 levels that is necessary for calcium efflux [37, 38]. Some 
studies indicate that in Xenopus neither PLCγ1 or PLCβ are necessary for IP3 production 
and the resulting Ca2+i  transients [38], while other studies support the idea that PLCγ is 
required at fertilization [39]. PLCγ activity is triggered by SFK activation [40]. 
 In the murine model, several membrane proteins are involved in the sperm-oocyte 
interaction. CD9  is a member of the tetraspanin superfamily of proteins.  Knockout CD9 
-/- female mice ovulate oocytes that exhibit a severe reduction in fertility, suggesting a 
key role for CD9 in fertilization [41-43]. Another protein with a role in fertilization is 
Izumo, an immunoglobulin superfamily member.  Izumo -/- male mice produce 
morphologically normal sperm, but are infertile because they cannot fuse with the oocyte 
vitelline membrane [44]. Substantial data supports the hypothesis that integrins mediate 
sperm-oocyte binding in mice [45-51]. Following sperm binding and fusion, it is believed 
that mouse oocyte activation is facilitated by PLCζ, a soluble sperm PLC isoform 
[52-55]. An endogenous mouse oocyte PLCβ1 has been proposed to work in synchrony 
with sperm PLCζ to drive Ca2+i and subsequent oocyte activation via IP3R [56]. In many 
of the animal models, members of SFK are used to relay the activation signal 
downstream to PLC. In the murine model, SRC activation appears not to be required for 
downstream Ca2+i transients and oocyte activation [57, 58]. In female mice lacking the 
SFK Fyn, there was a reduction of fertility, but this was attributed to cytoskeletal defects 
rather than a reduction in Ca2+i [59].  
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 Intracytoplasmic sperm injection (ICSI) may be used as tool to provide insight 
into the signal transduction pathway leading to oocyte activation among various animal 
models. ICSI consists of directly injecting an intact spermatozoa head into the ooplasm of 
an MII oocyte. This technique has been successfully used in hamsters for the past 34 
years [60]. Since 1992, ICSI has been successful in men with major oligospermia and 
asthenozoospermia [61]. ICSI has been performed in rabbits [62], hamsters [60], sheep 
[63, 64], cats [65, 66], mice [67, 68], goats [69-72], horses [73-76], pigs [77-79], cattle 
[80-82], humans [83-85], and baboons [86], with varying degrees of success. Although 
ICSI often must be accompanied by an activation step, usually in the form of a chemical 
activator such as ethanol, ionomycin, cycloheximide, or 6-dimethylaminopurine, this is 
not always essential.  ICSI alone can induce oocyte activation in humans [83, 87], mice 
[88], rabbits [62], and hamsters [60]. In these species, oocyte activation is solely 
facilitated either by the sperm head and its contents, such as a SOAF, or by the ISCI 
injection procedure that mechanically triggers activation.  ICSI alone, however, has not 
stimulated proper oocyte activation in the bovine [89]. The success of ICSI supports the 
hypothesis that oocyte activation occurs via a SOAF. This suggests that signal 
transduction pathways needed for oocyte activation can function in the absence of 
spermatozoa-vitelline membrane binding [89, 90]. The SOAF model appears sound  for 
species in which ICSI alone results in oocyte activation. But in species, such as cattle [80, 
91-97], that require an additional exogenous activator, receptor-mediated events appear to 
be required in addition to SOAF. One report indicates that less than 10% of bovine 
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oocytes subjected to ICSI alone showed Ca2+i  and that normal signal transduction 
pathways seen during natural fertilization were not replicated following ICSI [97]. 
 Previous work and findings reported here indicate that bovine oocyte activation is 
quite different from the mouse and may be more  similar to activation in Xenopus and the 
zebrafish.  To better understand the signal transduction pathways  of bovine oocyte 
activation and the role of SFK, the present study was conducted to: 1) learn if 
endogenous SFKs are present within bovine oocytes and spermatozoa; 2) determine the 
effect of SFKs antagonists and substrates on Ca2+i following fertilization, and 3) assess 
how SFKs antagonists and substrates affect cleavage rates 48 hours post fertilization.  
Materials and Methods
Reagents
All reagents were purchased from MP (ICN) Biomedical (Costa Mesa, CA) unless 
otherwise specified.
Oocyte Collection and In Vitro Maturation
All procedures were performed according to published methods [27, 98-101]. 
Briefly, bovine ovaries were collected from a local abattoir (JBS Swift & Company, 
Hyrum, UT) and transported to the laboratory for processing. Oocytes from 3-8 mm 
follicles were aspirated into 50-mL centrifuge tubes using an 18-gauge needle connected 
to a vacuum pump. Oocytes with intact multiple layers of cumulus cells and evenly 
shaded cytoplasm were selected and washed with PB1+ (Ca2+ and Mg2+ containing 
phosphate buffered saline, 0.32 mM sodium pyruvate, 5.55 mM glucose, 3 mg/mL BSA). 
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Oocytes were then transferred into 500 µL of maturation medium (MM), M199 
containing 10% fetal bovine serum (FBS; Hyclone Laboratories, Logan, UT), 0.5 µg/mL 
FSH (Sioux Biochemical, Sioux City, IA), 5 µg/mL LH (Sioux Biochemical), 100 units/
mL penicillin (Hyclone), and 100 µg/mL streptomycin (Hyclone) in 4-well culture dishes 
(Nunc, Milwaukee, WI) and cultured at 39ºC in a humidified atmosphere of 5% CO2 and 
air for 20-22 h.
Cumulus Cell Removal
 Cumulus cells were completely removed from mature oocytes by vortexing 
vigorously for 4 min 20 seconds in PB1+ containing 10 mg/mL hyaluronidase. Denuded 
oocytes were evaluated by microscopy and only oocytes with good morphology were 
used.  Selected oocytes were washed through 4 drops of PB1+ then randomly assigned to 
a treatment group and placed back in MM at 39ºC in a humidified atmosphere of 5% CO2 
to recover prior to microinjection.
Microinjection
 Thin-bore borosilicate glass capillaries were pulled into microinjection needles 
using a Narishige (East Meadow, NY) PB-7 pipette puller. Holding pipettes were 
similarly pulled and crafted using a Narishige MF-9 micro forge. Manipulation dishes 
were made using 100 µL PB1- (Ca2+ and Mg2+ free) drops under mineral oil. Cumulus-
free mature oocytes were microinjected using a Nikon Diaphot inverted microscope and 
Narishige IM 300 pneumatic micro-injector connected to compressed N2 gas with 
appropriate treatment. A typical bovine oocyte has a volume of ~800 pL.  The 
29
microinjection volume was calculated by assessing the formation of a  bubble under oil 
immersion and then measuring it by an ocular micrometer. A volume of ~8 pL (1/100 of 
the oocyte volume) was microinjected into each oocyte. Microinjection was assumed to 
result in a 100-fold dilution of any injected material. All data is represented as this 100-
fold diluted concentration. Groups of up to 20 oocytes were microinjected in batch to 
minimize the time oocytes were out of incubator. Microinjection volume was validated 
every 10 injections to ensure consistent injection volume. Sham controls were injected 
with vehicle medium, either ddH2O or DMSO. There were no observable differences 
between the vehicle medium groups (data not shown). Oocytes randomly assigned to IVF 
and No sperm groups were removed from incubation conditions and placed in a 
manipulation dish out of the incubator for equal time as other treatment groups. 
In Vitro Fertilization of Oocytes and Culture of Embryos
 After maturation, oocytes were fertilized and cultured in vitro (IVF) according to 
our standard laboratory procedures [100].  Frozen-thawed semen (Hoffman AI Breeders, 
Logan, UT) obtained from the same bull on multiple collection days, was separated by 
centrifugation for 30 min at 400-x gravity on a 45% over 90% Percoll (Sigma, St. Louis, 
MO) gradient.  The resulting pellet was washed with Sperm TL with 6 mg/ml BSA and 
centrifuged again at 65x gravity for 10 min.  The final pellet was diluted in Fertilization 
Medium (FM) containing 1 µg/mL heparin and 4% (v/v) PHE (2mM penacillamine, 1 
mM hypotaurine, 250 µM epinephrine).  Oocytes were washed through 4 drops of PB1+, 
and incubated in 4-well culture dishes containing 500 µL of sperm/FM for 6 h at 39ºC in 
a humidified atmosphere of 5% CO2 and air.  Fertilized oocytes were then removed from 
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sperm/FM and vortexed vigorously in PB1+ for 1 min to remove zona pellucida bound 
spermatozoa cells.  Denuded oocytes were cultured in 500 µL CR2 [101] containing 3% 
FBS over a monolayer of bovine cumulus cells at 39ºC in a humidified atmosphere of 5% 
CO2 and air.  Activation and development were assessed by identifying percent cleavage 
at day 2 of culture.
Visualization of Intracellular Calcium Transients
 After microinjection, oocytes were assigned to treatment groups. Where calcium 
visualization was necessary, oocytes were loaded with Ca2+ indicator by incubation in 2 
µM Fura-2 AM ester (Molecular Probes, Eugene, OR) and 0.02% Pluronic F-127 
(Molecular Probes, Eugene, OR) in PB1- for 45 min in darkness at 39°C.  Fura-2 loaded 
oocytes were washed extensively in 9 drops of PB1-, then 10 oocytes were placed in a 10 
µL micro drop of sperm/FM under mineral oil and incubated at 39ºC in a humidified 
atmosphere of 5% CO2 and air for 6 h. The control group with no sperm was placed in a 
10 µL micro-drop of FM. Following incubation with sperm, Ca2+i in the oocytes was 
measured for 30 minutes on an a Nikon Diaphot inverted microscope, coupled with a 
Hamamatsu ORCA-ER digital camera and analyzed using Metafluor Imaging Series 7.6 
software (Universal Imaging Corp, Downingtown, PA).  The oocytes were placed back in 
culture conditions for 1.5 hours, then Ca2+i visualization was repeated. Ca2+i transients 
were evaluated by ratio changes in florescence intensity at 340 nm and 380 nm. Oocytes 
assigned to the ionomycin control treatment were visualized for only the first interval. At 
that time all oocytes exhibiting Ca2+i  transients were removed and 1 µL of 1 mg/ml 
ionomycin was added to the drop containing remaining oocytes and Ca2+i transients were 
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then immediately measured for 30 minutes. Oocytes assigned to the IP3 treatment group 
were similarly measured for the first interval, then all oocytes exhibiting Ca2+i  transients 
were removed. The remaining ooyctes were microinjected with 0.0025 µM IP3 and Ca2+i  
transients were immediately measured for 30 minutes. 
Western Blot- Sperm sample preparation
 Sperm were capacitated with heparin and the acrosomal reaction with 
lysophosphatidylcholine was performed according to published protocols [102]. Briefly, 
frozen-thawed semen (Hoffman AI Breeders, Logan, UT) was washed in Sperm TL with 
6 mg/m BSA for 10 min at 400-x gravity. The resulting pellet was resuspended in 5ml 
Sperm TL and 1 µg/ml heparin and vortexed vigorously for 20 seconds. The suspension 
was separated into 500 µL aliquots and incubated with 5 mg/ml Lysophophotidly Choline 
for 15 minutes at 39°C. Aliquots were then centrifuged at 10,000 RPM for 10 minutes 
and the resulting pellet resuspended in 100 µL lysis buffer with protease inhibitor, 
vortexed and placed on a shaker at 4°C overnight. The aliquots were then centrifuged at 
10,000 RPM for 10 minutes at 4°C, further aliquoted into 25 µL volumes and then frozen 
at -80°C until Western blot analysis. 
Oocytes sample preparation
 Cumulus cells were removed as previously described, then 50 bovine oocytes 
were added to 6.5 µL double-strength sample buffer and 5 µL ddH2O in a 0.5 ml 
Eppendorf tube and frozen at -80ºC until use.
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 To confirm that primary antibodies would cross-react with predicted bovine 
proteins, protein was extracted from bovine brain. Briefly, 100 mg of ground brain tissue 
was placed in 10 ml 1X SDS buffer (1.25 M rTis HCl, 2% SDS, 10% glycerol, 0.001% 
Bromophenol Blue, 5% 2-mercaptoethanol), incubated in an Eppendorf Thermomixer® 
for 10 min at 70°C with maximum shaking, centrifuged at 16,000 x g at room 
temperature for 10 minutes. The supernatant was placed into a fresh tube and frozen at 
-20°C until use. Primary antibodies used are listed in Table 2-1.
 Western blot analysis of bovine SFKs was performed according to the procedures 
used by Sun and Fan [103]. Samples were boiled for 4 minutes, placed on ice for 5 
minutes, and centrifuged at 12,000g for 3 minutes.  Total proteins were separated by 
SDS-page with a 4% stacking gel and a 10% separating gel for 45 minutes at 110 V and 
115 mA (Pierce Precise Protein Gels), while the nitrocellulose membrane and filters were 
incubated in the transfer buffer at 4ºC for 45 minutes.  After electrophoresis, the gel was 
washed with transfer buffer for 15 minutes and then the total protein was transferred 
electrophoretically onto the nitrocellulose membrane for 60 minutes at 20 V and 350 mA.  
Upon transfer, the membrane was washed twice with Tris-buffered saline (TBS; 20mM 
Tris-HCL, 137mM NaCL, pH 7.4) for 5 minutes each time and then the membrane was 
blocked overnight at 4ºC in Tris-buffered saline with Tween (TBST; 20mM Tris-HCL, 
137mM NaCL, 0.1% Tween-20, pH 7.4) with 5% skim milk.  To detect bovine SFK- the 
membrane was incubated for 1 hour with a specific primary antibody diluted 1:100 in 
TBST, washed 3 times in TBST for 10 minutes each, incubated for 1 hour at 37ºC with 
appropriate HRP-labeled secondary antibody diluted 1:1000 in TBST, and finally 
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processed as described below.  The nitrocellulose membrane was washed twice with 
TBST, 5 minutes each time.  For protein detection one part Opti-4CN diluent concentrate 
was mixed with nine parts ddH2O (BioRad Opti-4CN Substrate Kit). A 0.2 ml volume of 
Opti-4CN substrate was added to 10 mls of diluent, mixed thoroughly, and poured onto 
the membrane.  The membrane was incubated with gentle agitation in the substrate for 30 
minutes and washed in ddH2O for 15 minutes.  
Results
SFKs in Bovine Oocytes and Spermatozoa
 Western blotting determined that SRC, BLK, YES, and FYN are present in both 
IVM matured bovine oocytes and acrosome-reacted bovine spermatozoa.  LYN and HCK 
are present in acrosome-reacted bovine spermatozoa only. Neither LCK, or FGR were 
detectable in either bovine gamete (Figure 2-1). These findings were confirmed by 2-4 
replications and through a secondary antibody control experiment, where no primary 
antibody was used (data not shown).
Impacts of Injectants on Intracellular Calcium Transients
 IP3 control groups were processed as follows; Ca2+i  was measured for 30 minutes, 
any oocytes that exhibited Ca2+i  were removed. Remaining oocytes were microinjected 
with 0.0025 µM IP3, and Ca2+i  transients were immediately measured for 30 minutes. 
The IP3 control validated that the signal transduction pathway leading to Ca2+i was 
functional and in operation. It further confirmed that inhibitors were functioning 
upstream of IP3 involvement. IVF control groups were removed from the incubator and 
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placed on the microscope stage while treatment groups were injected to mimic 
conditions. No sperm negative control groups were placed in fertilization medium with 
no sperm. Microinjection of SRC Peptide non-phosphorylated (SRCPnp), followed by 
IVF, had no impact (P > 0.05) on Ca2+i at any treatment concentration when compared to 
IP3 and IVF positive controls.
 Microinjection of PP2, a known inhibitor of Src, Lck, Fyn, and FAK resulted in a 
significant (P < 0.05) reduction in Ca2+i at all treatment concentrations relative to positive 
controls. There was no difference (P > 0.05) between the 3 µM PP2 treatment and the no 
sperm control (Figure 2-2 and Table 2-2). Microinjection of the phosphorylated version 
of SRC Peptide (SRCPP) prior to IVF had a dose-dependent impact on Ca2+i. The 
concentrations of 2 µM and 0.02µM SRCPP showed no difference (P > 0.05) from the no 
sperm control (Figure 2-2 and Table 2-2).  Microinjection of Src Substrate II non-
phosphorylated (SSIInp) resulted in a significant (P < 0.05) reduction in Ca2+i response at 
all concentrations as compared to positive controls. No difference (P > 0.05) was 
observed among any treatment concentration when compared to the negative control 
(Figure 2-2 and Table 2-2). Microinjection of the phosphorylated version of SSII (SSIIP) 
also resulted in a significant (P < 0.05) reduction in Ca2+i response at all treatment 
concentrations. The concentrations of 2µM and 0.2µM SSIIP showed no difference from 
the no sperm control (Figure 2-2 and Table 2-2). 
Impact of Injectants on Cleavage Rates
 Using cleavage rate as a marker for activation provided helpful insight into the 
impacts of injectants. Oocytes within treatment groups were injected with various 
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compounds followed by IVF for 6 hrs, and then cleavage rates were then assessed on day 
2 of culture. The positive controls, IVF and sham, controls were not injected (IVF) or 
injected with vehicle medium (sham) followed by 6 hr fertilization and 48 hr culture prior 
to cleavage assessment. 
 Microinjection of PP2 had a significant (P < 0.05) decrease on cleavage. 
Treatment 3 µM PP2 showed no significant difference (P > 0.05) from the negative no 
sperm controls (Figure 3 and Table 2). Microinjecting SRCnPp prior to IVF showed no 
decrease in cleavage rates compared to positive controls. Microinjecting the 
phosphorylated version, SRCPP, showed a significant (P < 0.05) decrease in cleavage rate 
with the 0.02µM and 2µM SRCPP groups (Figure 2-3 and Table 2-2).  
Discussion 
 A rise in Ca2+i is a hallmark of oocyte activation, although the specific pathway 
leading to oocyte activation differs between species. To better understand the signal 
transduction pathway  for bovine oocyte activation and  to examine the potential 
involvement of SFKs, the present study was carried out to: 1) identify the specific 
endogenous SFKs present within bovine oocytes; 2) identify the specific endogenous 
SFKs found within bovine spermatozoa, 3) determine the impact of different SFK 
antagonists and substrates on Ca2+i following fertilization; and 4) determine the impact of 
SFK antagonists and substrates on cleavage 48 hours post fertilization.
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Endogenous SFKs in Bovine Oocyte and Spermatozoa
 A previous study reported that SRC is present in pre-acrosome reacted bovine 
spermatozoa and plays a role in the acrosome reaction [104]. It was  unknown if other 
SFKs are present in bovine spermatozoa, and if they were involved in oocyte activation. 
SFK’s are associated with the cytosolic side of plasma membranes through its 
myristoylated N-terminus [105]. In this study, capacitated and acrosome reacted 
spermatozoa were lysed for Western blot analysis of SRKs. This preparation of 
spermatozoa reflects the physiological state of a sperm as it contacts the vitelline 
membrane. Because these spermatozoa were acrosome-reacted, any SFKs associated with 
the outer acrosome membrane were eliminated. Bovine brain extracts were used in 
conjunction with positive controls to confirm that all the SFK antibodies cross-reacted 
with bovine proteins. 
 The major SFKs in both bovine oocytes and spermatozoa were identified. BLK, 
YES, SRC, and FYN were all present within both bovine oocytes and spermatozoa, as 
shown in Figure 2-1 (A). BLK showed strong signals in all Western blot lanes and YES 
showed moderate signal strength across all samples. Both BLK and YES showed a size 
shift relative to the bovine brain extract lane. This size difference might be due to 
differential phosphorylation or other post-translational modifications. LYN and HCK 
were observed in bovine spermatozoa, but absent in bovine oocytes (Figure 2-1, B) but at 
low signal strength. No SFK’s were detected in bovine oocytes alone. 
37
The SFK Inhibitor, PP2, Significantly Decreased Ca2+i and Cleavage Rates
 PP2, a known inhibitor of multiple SFKs, was used to evaluate potential roles of 
for SFKs in oocyte activation.  Microinjecting 3µM PP2 abolished  Ca2+i transients and 
cleavage.  This indicates that one or more SFKs are involved in bovine oocyte activation. 
It is interesting to note that PP2 inhibits the activation of FAK, which is known to 
associate with integrin receptor molecules. Integrin-mediated cell adhesion typically 
induces FAK to become highly phosphorylated and transduce a signal based on its ability 
to interact with a number of signaling effectors from the SFK [106]. Integrins have been 
detected in bovine oocytes [107] and have been shown to play a role in bovine oocyte 
activation [98, 108].
SRC is Involved in Bovine Oocyte Activation 
 We selected specific peptides that target SRC protein and used these to evaluate 
SRC’s involvement in Ca2+i and subsequent cleavage following IVF. SRCPnp is a thirteen 
amino acid peptide that mimics the non-phosphorylated C-terminal phosphoregulatory 
region of SRC. Microinjection of this peptide had no effect on SRC protein’s ability to 
induce Ca2+i  and cleavage. However, a phosphorylated from of this same peptide 
(SRCPP) that is phosphorylated within the regulatory region at Tyr527, blocked signal 
transduction. Experiments evaluating Ca2+i indicate that SRCPP has a major impact in 
blocking signal transduction leading to bovine oocyte activation.  The SRCPP 2µM 
treatment blocked calcium-signaling resulting in only 8/56 (14.3%)d oocytes exhibiting a 
Ca2+I. There was no difference between this treatment and the no sperm control 3/25 
(12.0%)d.   The percent cleavage observed in the SRCPnp treatments were consistent with 
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the Ca2+i results, which indicated no difference between IVF and sham injection controls.  
The percent cleavage for SRCPP treated oocytes indicated that 31/72 (43.1%)b cleaved at 
0.02µM and 40/118 (33.9%)b at 2µM levels. Both treatments were different from controls 
884/1200 (73.7%)a IVF, 372/492 (75.6%)a sham injection, and 90/639 (14.1%)c*,d no 
sperm controls. It is unclear why a difference was observed between Ca2+i and cleavage 
data following the 0.02µM SRCPP injection. Ca2+i is measured after a 6 hour fertilization 
and cleavage rates are evaluated after a 6 hour fertilization and a 48 hour culture period. 
This slight increase observed in cleavage over Ca2+i response may result from the 
increased time required for assessing these two different activation parameters. The 
increased incubation time required to evaluate cleavage rate may provide a window for 
endogenous oocyte phosphatase to remove the inhibitory phosphate from Tyr527, thus 
facilitating signal transduction and cleavage. There was no delay observed in activation 
when evaluating Ca2+i. 
 Based upon the combination of Ca2+i responses and cleavage rate data using 
SCRPnp and SRCPP, I hypothesize that as the inhibitory phosphate is removed from the 
endogenous SRC protein in the phosphoregulatory region at Tyr527, the SH2 domain 
becomes unbound from the C-terminal phosphoregulatory region, making it available for 
the microinjected SRCPP to bind to the SH2 domain, and thus inhibit downstream signal 
transduction. The data indicates that SRC protein is involved in the signal transduction 
events leading to Ca2+i and subsequent cleavage in bovine oocytes.
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IVF Activates SRC Protein and Injection of SRC Substrate Sequesters the Signal
  As SRC is activated, it induces activation of downstream Src Substrate II (SSII) 
via phosphorylation. Microinjection of Src Substrate II non-phosphorylated (SSIInp) had 
a significant impact on Ca2+i response at all treatment concentrations, as none were 
statistically different from the no sperm control. Cleavage rates also decreased at 
treatments 0.2µM, 31/90 (34.4)c and 2µM, 29/87 (33.3)c , indicating that SSIInp was able 
to sequester any signal produced by upstream SRC activation. 
 Micro-injecting SSIIP, a phosphorylated form of the SSII peptide, had significant 
effects on Ca2+i responses at all concentrations. Oocytes injected at concentrations 0.2µM 
and 2µM SSIIP  behaved indistinguishably from  the no sperm control. SSIIP induced a 
concentration-dependent decrease in cleavage rates.  Microinjection of SSIIP at 2µM 
provided the greatest decrease in activation, as assessed by cleavage rate. Based upon the 
combined results of SSIInp and SSIIP Ca2+i responses and cleavage data, we conclude 
that endogenous bovine SRC protein is activated following IVF and injected SSIInp and 
SSIIP was available to sequester the signal transduction leading to oocyte activation. The 
data supports the involvement of SRC protein in the signal transduction pathway leading 
to bovine oocyte activation. Taken together, all of this data support the conclusion that the 
SRC protein is involved in bovine oocyte activation.
 SFKs play a role in oocyte activation in sea urchin, ascidian, starfish, Xenopus, 
and zebrafish [28-32, 39]. In the murine model, SFKs have been reported as unnecessary 
for Ca2+i at oocyte activation in mice [57, 58]. These findings have caused many 
researchers to conclude SFKs are therefore not necessary for fertilization of other 
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mammals. Generalizing from one mammalian model without conclusive evidence from 
other models can be misleading. For example, a comparative evaluation of the success of 
ISCI support the idea that pathways leading to oocyte activation may differ among 
species. ISCI alone is sufficient to properly activate hamster [60], rabbit [62], human [83, 
87], and murine oocytes [88], but bovine oocytes require an additional activation step 
[89].  In this report we provide evidence that, unlike the mouse, SRC plays a vital role in 
bovine oocyte activation. These findings reinforce the conclusion that not all mammalian 
species are similar in their biochemical mechanisms of fertilization and urge caution 
against generalizing from research on fertilization in any single model system.   
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Table 2-1. Primary antibodies used for western blotting. Amino acid numbers from Santa 
Cruz antibodies are not available, except for LYN (H-6): sc.-7274.
SFK Antibody (source) Epitope
SRC mAB327 (EMD OP07) SH3 domain
BLK K-23: sc-329 (Santa Cruz) N-terminus
YES 3: sc-14 (Santa Cruz) N-terminus
FGR C-1: sc-17 (Santa Cruz) C-terminus
FYN FYN3: sc-16 (Santa Cruz) N-terminus
HCK M-28: sc-1428 (Santa Cruz) N-terminus
LCK 2102: sc-13 (Santa Cruz) C-terminus
LYN H-6: sc-7274 (Santa Cruz) Amino acids 40-70, near N-terminus
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Table 2-2. Effect of peptides, substrates, and inhibitors on oocyte activation as 
determined Ca2+i. a-d Unlike superscripts are significantly different (P<0.05). 
Comparisons are made within treatments and against controls.
Treatment Number of matured oocytes Number of oocytes showing Ca2+i
Inomyocin
IP3
IVF Control
No Sperm
 SrcPnp 0.02 µM
 SrcPnp 0.2 µM
SrcPnp 2 µM
SrcPP 0.002 µM
 SrcPP 0.02 µM
 SrcPP 2 µM
PP2 0.004 µM
 PP2 0.25 µM
PP2 3 µM
SSIInp 0.02 µM
SSIInp 0.2 µM
SSIInp 2 µM
SSIIP 0.02 µM
SSIIP 0.2 µM
SSIIP 2 µM
31 31 (100)a
46 38 (82.6)a,b
346 241 (69.7)b
25 3 (12.0)d
23 15 (65.2)b
26 17 (65.4)b
31 22 (71.0)b
25 13 (52.0)b,c
27 9 (33.3)c,d
56 8 (14.3)d
47 24 (51.1)c
30 11 (36.7)c
51 11 (21.6)c,d
30 10 (33.3)c,d
40 12 (30.0)c,d
63 18 (28.6)c,d
28 14 (50.0)c
25 9 (36.0)c,d
43 8 (18.6)d
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Table 2-3. Effect of peptides, substrates, and inhibitors on development as determined 
by cleavage after IVF. a-d Unlike superscripts are significantly different (P < 0.05). 
Comparisons are made within treatments and against controls. c* makes comparison 
between these groups only.
Treatment Number of matured oocytes Number of oocytes cleaved
IVF Control
Sham Injection
No Sperm
 SrcPnp 0.02 µM
 SrcPnp 0.2 µM
SrcPnp 2 µM
SrcPP 0.002 µM
 SrcPP 0.02 µM
 SrcPP 2 µM
PP2 0.004 µM
 PP2 0.25 µM
PP2 3 µM
SSIInp 0.02 µM
SSIInp 0.2 µM
SSIInp 2 µM
SSIIP 0.02 µM
SSIIP 0.2 µM
SSIIP 2 µM
1200 884 (73.7)a
492 372 (75.6)a
639 90 (14.1)c*,d
23 15 (65.2)a
26 17 (65.4)a
31 22 (71.0)a
47 35 (74.5)a
72 31 (43.1)b
118 40 (33.9)b
89 37 (41.6)b
185 61 (33.0)b
190 37 (19.5)c*
122 61 (50.0)b
90 31 (34.4)c
87 29 (33.3)c
172 122 (70.9)a
200 115 (57.5)b
285 96 (33.7)c
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Figure 2-1. Western blots of SFK proteins in bovine gametes and bovine negative and 
positive control cell lysates. The bovine control was bovine brain lysate and the postive 
controls were Jurkat, RAW 364.7, Namalwa, 293T, or BJAB cells. (A) SFKs detected in 
both bovine oocytes and bovine spermatozoa. (B) SFKs detected in bovine spermatozoa 
only. (C) SFKs not detected in bovine oocytes or spermatozoa. 
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CHAPTER 3
INVOLVEMENT OF PHOSPHOLIPASE C ISOTYPES IN THE ACTIVATION 
OF BOVINE OOCYTES
Abstract
 At fertilization, a sperm cell induces the oocyte to leave its state of metabolic 
arrest and resume metabolism in the process of activation.  A defining feature of 
activation is the release of intercellular calcium (Ca2+i) from the endoplasmic reticulum 
(ER) that results in repetitive Ca2+i transients. There is little known about the mediators of 
bovine oocyte activation, while sea urchin, zebrafish, ascidian, starfish, Xenopus, and 
murine models are better defined. It is well accepted that the activation of Phospholipase 
C (PLC) results in the cleavage of phosphatidylinositol 4,5-bisphosphate (PIP2), 
producing membrane-bound diacylglycerol (DAG) and cytosolic soluble 1,4,5-inositol 
trisphosphate (IP3). The binding of IP3 to its ER receptor leads to the release of Ca2+i 
within the oocyte. In this study we investigated the six PLC isotypes and their potential 
role in bovine oocyte activation.  To determine the role of PLC isotypes in Ca2+i release 
and cleavage, PLC antibodies were microinjected into mature bovine oocytes followed by 
in vitro fertilization (IVF). Western blotting was used to confirm the presence of specific 
PLC proteins within bovine oocytes and spermatozoa. The inhibition of several PLC 
isotypes was shown to significantly decrease Ca2+i and cleavage rates. These data identify  
which PLC isotypes and isozymes are involved in bovine oocyte activation and further 
confirm that the detailed pathway leading to oocyte activation differs among animal 
models.
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Introduction
	
 Bovine oocytes are ovulated immature at metaphase II (MII) and must undergo 
activation to exit this state of metabolic arrest. The fertilizing sperm initiates activation, 
which is critical for embryonic development. Oocyte activation includes cortical granule 
exocytosis, repetitive intercellular calcium (Ca2+i) transients, pronuclear formation, 
second polar body extrusion, DNA synthesis, resumption and completion of meiosis II, 
and embryonic development [1, 2]. Ca2+i plays an important role in cortical granule 
exocytosis, which provides a block to polyspermy [3-5]. The role that Ca2+i transients 
play in activation is not fully understood, but is believed to act as a second messenger 
that initiates down-regulation of maturation promoting factor (MPF) activity [6]. A 
decrease in MPF induces the oocyte to re-enter the cell cycle and exit MII arrest. 
 The signal transduction pathway leading to Ca2+i has been explained by two 
competing hypotheses [7]. The receptor mediated hypothesis proposes a sperm ligand 
binds to a receptor on the vitelline membrane of the oocyte. There are three likely 
receptor candidates, G-protein coupled receptors, integrins, and/or receptor tyrosine 
kinase. These receptors are known to activate Phospholipase C (PLC), which cleaves 
phosphatidylinositol 4,5-bisphosphate (PIP2), producing membrane-bound diacylglycerol 
(DAG) and cytosolic soluble 1,4,5-inositol trisphosphate (IP3). The binding of IP3 to its 
endoplasmic reticulum IP3 receptor (IP3R) leads to the release of Ca2+i within the cytosol 
of the oocyte [8, 9].
 The sperm-borne oocyte-activating factor (SOAF) [10] proposes that when 
spermatozoa fuse with the oocyte vitelline membrane, SOAF is deposited into the oocyte, 
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which then interacts with cytosolic proteins to produce downstream Ca2+i through the 
pathway described above. It is well accepted that Ca2+i stores come from the ER [11-18]. 
Ryanodine receptors (RyR) play a parallel role with IP3R in Ca2+i and calcium-induced 
calcium release (CICR) in many fish and echinoderm oocytes. RyR have also been shown 
to operate in CICR in bovine [19, 20] and within murine oocytes [21]. Whether through 
IP3R alone or IP3/RyR combined pathways, Ca2+i is a hallmark of oocyte activation for 
all animal models studied to date. 
	
 Oocyte activation pathways in models such as sea urchin, zebrafish, ascidian, 
starfish, Xenopus, and murine models have been extensively studied, but little 
information is available for the bovine model. Similar activation pathways are found for 
sea urchin, ascidian, and starfish activation. This involves the activation of Src Family 
Kinase (SFK), which then activates PLCγ.  Enzymatically active PLCγ can then cleave 
PIP2 to produce IP3, which leads to Ca2+i release from the ER [2, 8, 22, 23]. The 
activation pathway in zebrafish is more clearly defined as the specific SFK Fyn and/or 
Src are activated prior to PLCγ activation [24].  Xenopus oocyte activation is facilitated 
through multiple pathways. It has been shown that contact with cathepsin B [25], 
peptides containing the integrin-binding RGD sequence [26], or a disintergrin region of 
testes derived cDNA that codes for a metalloprotease/disintegrin termed xMDC16 [27] 
can all activate Xenopus oocytes. Further, the Xenopus spermatozoa post-acrosomal 
sheath WW domain binding protein produces Ca2+i [28]. After fertilization there is an 
increase in IP3 concentration that is essential for Ca2+i release in Xenopus [29, 30]. 
Conflicting results indicate that neither PLCγ1 nor PLCβ are necessary for IP3 
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production and the resulting Ca2+i transients [30], while other studies support that PLCγ is 
required [11] and is made active by SFK [31]. 
 Considerable data supports the idea that in murine, integrins mediate sperm-
oocyte binding [32-40] followed by oocyte activation by SOAF PLCζ isotype [41-44]. 
Endogenous oocyte PLCβ1 has been proposed to function in synchrony with PLCζ to 
produce Ca2+i transients and oocyte activation via IP3R [45]. 
  Additional insight into the signal transduction pathway can be provided by 
intracytoplasmic sperm injection (ICSI), which involves the direct injection of 
spermatozoa into the cytoplasm of a MII oocyte. This procedure was first demonstrated 
in hamsters [46] and is routinely used in human reproductive medicine, with the first 
cases dating back to 1992 [47]. ICSI has been performed in multiple species, hamsters 
[46], rabbits [48], cats [49, 50], mice [51, 52], goats [53-55], pigs [56-58], baboons [59], 
horses [60-62], cattle [63-65], and humans [66, 67] with varying degrees of success. 
 Just as in somatic cell nuclear transfer, ICSI must often be accompanied by an 
activation step, typically using a chemical activator such as ethanol, cycloheximide, 6-
dimethylaminopurine, or ionomyocin. However, humans [66, 68], mice [69], hamsters 
[46], and rabbits [48] do not require activation as ICSI alone induces oocyte activation. 
For these species, oocyte activation is accomplished by the spermatozoa and its contents, 
possibly a SOAF, or mechanically by the ICSI procedure. The SOAF hypothesis is 
supported by the success of ICSI without the use of exogenous agents to induce 
activation in these species, since there is no need for spermatozoa-vitelline membrane 
binding and all membrane receptors are bypassed by injection. This implies that that 
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proper signal transduction can occur without receptor binding [70]. The SOAF model of 
oocyte activation is reasonable for species in which ICSI alone initiates oocyte activation. 
This is not true for bovine, since ICSI alone does not induce proper oocyte activation and 
subsequent development without an additional exogenous activator to induce activation 
[63, 71-77]. It appears that in cattle a receptor interaction between spermatozoa-vitelline 
membrane is required for oocyte activation. One report indicates that < 10% of bovine 
oocytes subjected to ICSI alone showed Ca2+i transients and that typical signal 
transduction pathways seen during natural fertilization were not replicated [77]. 
 Previous work and data reported here indicate that bovine oocyte activation is 
different from other mammalian models and may more closely resemble pathways found 
in Xenopus and the zebrafish. To better understand the signal transduction pathway in 
bovine oocyte activation and the role of PLC isotypes this study was conducted to: 1) 
determine which PLC isotypes are present in bovine gametes, 2) determine the impact 
microinjecting antibodies against PLC isotypes have on Ca2+i transients following IVF, 3) 
determine the impact microinjecting antibodies against PLC isotypes have on cleavage 
rates 48 hr post IVF.   
Materials and Methods
Reagents
Reagents were purchased from MP Biomedical (Costa Mesa, CA) unless 
otherwise specified.
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Oocyte Collection and In Vitro Maturation
All procedures were performed according to published methods [20, 21, 78-80]. 
Briefly, bovine ovaries were collected from a local abattoir (JBS Swift & Company, 
Hyrum, UT) and immediately processed. Oocytes were aspirated from follicles 3-8mm in 
size into 50-mL tubes using a 18-gauge needle and a vacuum pump. Oocytes were 
washed with PB1+ (Ca2+ and Mg2+ containing phosphate buffered saline, 0.32 mM 
sodium pyruvate, 5.55 mM glucose, 3 mg/mL BSA), transferred into 500 µL of 
maturation medium (MM), M199 containing 10% fetal bovine serum (FBS; Hyclone 
Laboratories, Logan, UT), 0.5 µg/mL FSH (Sioux Biochemical, Sioux City, IA), 5 µg/
mL LH (Sioux Biochemical), 100 units/mL penicillin (Hyclone), and 100 µg/mL 
streptomycin (Hyclone) in 4-well culture dishes (Nunc, Milwaukee, WI) and cultured at 
39ºC in a humidified atmosphere of 5% CO2 and air for 20-22 h.
Cumulus Cell Removal
 Cumulus cells were removed from in vitro matured (IVM) oocytes by vortexing 
for 5 mins in PB1+ containing 10 mg/mL hyaluronidase. Oocytes were then washed 
through 4 drops of PB1+, randomly assigned to treatment groups and placed back in fresh 
MM to recover prior to microinjection.
Microinjection
 Microinjection needles were pulled using thin-bore borosilicate glass capillaries 
and a Narishige (East Meadow, NY) PB-7 pipette puller. Holding pipettes were crafted 
using a Narishige MF-9 micro forge. Micro-manipulation dishes were made with 100 µL 
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PB1- (Ca2+ and Mg2+ free) drops under mineral oil. IVM cumulus-free oocytes were 
microinjected with appropriate treatment using compressed N2 gas, a Narishige IM 300 
pneumatic, and a Nikon Diaphot inverted microscope. The microinjection volume was 
determined by measuring a bubble formed under oil immersion by an ocular micrometer. 
Each oocyte was microinjected with ~8 pL (1/100 of a typical oocyte volume) of 
appropriate treatment, resulting in a 100-fold dilution of any injected material. All data is 
represented at this 100-fold diluted working concentration. Groups of 20 oocytes were 
injected at a time to minimize time out of the incubator. After 10 oocytes, the 
microinjection volume was checked to ensure consistent injection volume. All sham 
controls were injected with ddH2O. All oocytes in IVF and no sperm control groups were 
removed from the incubator and placed in a manipulation dish for an equal amount of 
time as other treatment groups.  
In Vitro Fertilization of Oocytes and Culture of Embryos
 Between 21-24 h maturation, oocytes were fertilized according to our standard 
laboratory procedures.  Frozen-thawed semen (Hoffman AI Breeders, Logan, UT) was 
separated on a 45% over 90% Percoll (Sigma, St. Louis, MO) at 400-x gravity for 30 
min.  The pellet was then washed with Sperm TL containing 6 mg/ml BSA and 
centrifuged at 65x gravity for 10 min.  The final pellet was resuspended in Fertilization 
Medium (FM) containing 1 µg/mL heparin and 4% (v/v) PHE (2mM penacillamine, 1 
mM hypotaurine, 250 µM epinephrine).  Oocytes were fertilized in 4-well culture dishes 
containing 500 µL of sperm/FM at 39ºC in a humidified atmosphere of 5% CO2 and air 
for 6 h at which time were removed and vortexed vigorously in PB1+ for 1 min to 
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remove bound spermatozoa cells.  Oocytes were then cultured in 500 µL CR2 [80] at 
39ºC in a humidified atmosphere of 5% CO2 and air.  On day 2 of culture proper 
activation and development were assessed by identifying percent cleavage.
Visualization of Intracellular Calcium Transients
 Oocytes assigned to calcium visualization were incubated in 2 µM Fura-2 AM 
ester (Molecular Probes, Eugene, OR) and 0.02% Pluronic F-127 (Molecular Probes, 
Eugene, OR) in PB1- for 45 min in darkness at 39°C. Groups of 10 oocytes were then 
washed extensively in 9 drops of PB1- and placed in a 10 µL micro drop of sperm/FM 
under mineral oil and incubated at 39ºC in a humidified atmosphere of 5% CO2 and air 
for 6 h. The no sperm control group were placed in a 10 µL micro-drop containing FM 
only. Following fertilization, Ca2+i was measured for a first 30 min interval on an a Nikon 
Diaphot inverted microscope, coupled with a Hamamatsu ORCA-ER digital camera and 
analyzed using Metafluor Imaging Series 7.6 software (Universal Imaging Corp, 
Downingtown, PA).  After visualization, oocytes were placed back in incubation 
conditions for 1.5 h, then Ca2+i visualization was repeated for an second 30 min interval. 
Ca2+i transients were determined by ratio changes in florescence intensity at 340 nm and 
380 nm wavelengths. Oocytes in the ionomycin control treatment were only visualized 
during the first interval, at which time oocytes showing Ca2+i  transients were removed 
from the microdrop and 1 µL of 1 mg/ml ionomycin was added and Ca2+i transients were 
then immediately measured for 30 min. Oocytes used in the IP3 treatment group were 
similarly evaluated for the first interval only. All oocytes exhibiting Ca2+i  transients were 
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removed. The remaining ooyctes were then microinjected with 0.0025 µM IP3 and Ca2+i  
transients were immediately measured for 30 min.
CICR, IP3R, and RyR Experiments Using PLC η2 and PLC δ4
	
 To better understand the role of PLC η2 and PLC δ4 in both Ca2+i transients and 
cleavage rates the following was conducted. Following IVM and cumulus cell removal, 
oocytes were allowed to recover for 1-2 h. At 21-22 h post maturation cumulus free 
oocytes were micro-injected with ~8pL of the given PLC isotype. For those randomly 
assigned to Ca2+i visualization they were incubated in 2 µM Fura-2 AM ester (Molecular 
Probes, Eugene, OR) and 0.02% Pluronic F-127 (Molecular Probes, Eugene, OR) in PB1- 
for 45 min in darkness at 39°C. Groups of 5 oocytes were then washed extensively in 9 
drops of PB1- and placed in a 500 µL of sperm/FM in a 4-well dish and incubated at 
39ºC in a humidified atmosphere of 5% CO2 and air for 6 h. Oocytes were then removed 
from sperm/FM, vortexed for 1 min, washed through 3 drops of PB1- and placed in a 10 
µL drop of PB1- under mineral oil. Oocytes were then micro-injected with either 200 µM 
procaine or 1 mg/ml heparin and immediately Ca2+i was visualized as described above. 
For oocytes randomly assigned to cleavage groups they were micro-injected with the 
given PLC isotype 21-22 h post maturation, fertilized for 6 h, vortexed for 1 min, micro-
injected with either 200 µM procaine or 1 mg/ml heparin, placed in 500 µL CR2 and 
incubated at 39ºC in a humidified atmosphere of 5% CO2 and air for 48 h prior to 
cleavage assessment. 
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Western Blot 
Sperm and oocyte sample preparation
 Sperm were capacitated with heparin and acrosome reacted with 
lysophosphatidylcholine according to published protocols [81]. Quickly, frozen-thawed 
semen (Hoffman AI Breeders, Logan, UT) was washed suspended in Sperm TL with 6 
mg/m BSA and centrifuged at 400-x gravity for 10 min. The pellet was resuspended in 
5ml Sperm TL and 1 µg/ml heparin and vortexed for 20 seconds. The suspension was 
divided into 500 µL volumes with 5 mg/ml Lysophosphatidly Choline, and incubated for 
15 min at 39°C. The suspension was then centrifuged at 10,000 RPM for 10 min and the 
resulting pellet resuspended in 100 µL lysis buffer with protease inhibitor, vortexed and 
placed on a shaker at 4°C overnight. The aliquots were then centrifuged at 10,000 RPM 
for 10 min at 4°C, further aliquoted into 30 µL volumes and frozen at -80°C. 
 Cumulus cells were removed as previously described, then 50 bovine oocytes 
were washed through 4 drops of PBS and added to 5 µL double-strength sample buffer 
and frozen at -80ºC until use.
Bovine tissue sample preparation
 To confirm that primary antibodies would cross-react with bovine, protein was 
extracted from bovine brain, lung, liver, lymph node, and testis using the same procedure. 
Briefly, 1g of frozen bovine tissue was diced into small thin pieces using a razor blade 
and disrupted and homogenized in 5 ml 1X SDS buffer (1.25 M rTis HCl, 2% SDS, 10% 
glycerol, 0.001% Bromophenol Blue, 5% 2-mercaptoethanol) and protease inhibitor, then 
incubated on ice for 30 min. The mixture was then transferred to micro-centrifuge tubes 
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and centrifuged at 10,000g for 10 min at 4ºC. The supernatant was removed and placed in 
a clean centrifuge tube and again centrifuged at 10,000g for 10 min at 4ºC. Centrifugation 
was repeated until a clear lysate was obtained. Primary antibodies used are listed in Table 
3-1.
 Western blot analysis of bovine PLC’s was performed according to the procedures 
used by Sun and Fan [82]. Samples were boiled for 5 min, placed on ice for 5 min, and 
centrifuged at 10,000g for 1 min.  Total proteins were separated by SDS-page with a 8% - 
16% Pierce Precise Protein Gel for 45 min at 150 V and 120 mA at 4ºC for 45 min.  After 
electrophoresis, the gel was washed with transfer buffer (39 mM glycine, 48 mM rTis, 
0.037% SDS, and 20% methanol) for 15 min and then the total protein was transferred 
electrophoretically onto the nitrocellulose membrane for 60 min at 20 V and 350 mA.  
Upon transfer, the membrane was washed twice with Tris-buffered saline (TBS; 20mM 
Tris-HCL, 137mM NaCL, pH 7.4) for 5 min each time and then the membrane was 
blocked overnight at 4ºC in TBS with 5% skim milk.  To detect bovine PLC’s- the 
membrane was incubated for 1 h with a specific primary antibody diluted 1:200 in Tris-
buffered saline with Tween (TBST; 20mM Tris-HCL, 137mM NaCL, 0.1% Tween-20, 
pH 7.4) and 5% skim milk, washed 3 times in TBST for 10 min each, incubated for 1 h at 
37ºC with appropriate HRP-labeled secondary antibody diluted between 1:1000 - 1:5000 
in TBST with 5% skim milk.  The nitrocellulose membrane was then washed twice with 
TBST and once in TBS for 5 min.  For protein detection, 1.1 ml Opti-4CN diluent 
concentrate was mixed with 11 ml ddH20 and 0.242 ml volume of Opti-4CN substrate 
(BioRad Opti-4CN Substrate Kit), mixed thoroughly, and poured onto the membrane.  
72
The membrane was incubated with gentle agitation in the substrate for 30 - 60 min and 
washed in ddH2O for 15 min.
  
Results
	
 PLC Isotypes in Bovine Oocytes and Spermatozoa
Western blotting indicated that PLC δ1 and PLC δ3 are present in both bovine oocytes 
and acrosome-reacted bovine spermatozoa. PLC δ4, PLC γ2, and PLC η2 are present in 
bovine oocytes, but not detected in bovine spermatozoa. PLC ζ is present in bovine 
sperm but did not have any impact on Ca2+i or the cleavage rates (Figure 3-1). PLC β1, 
PLC β2, PLC β3, PLC β4, PLC ε, and PLC γ1 were not detected in either bovine oocytes 
or bovine spermatozoa (data not shown). 
Impact of PLC Isotypes on Intracellular Calcium Transients
 Micro-injecting PLC β1, PLC β2, PLC β3, PLC β4, PLC ε, PLC η2, PLC δ4, and 
PLC γ1 had no effect on Ca2+i when compared to IVF and Sham controls (P>0.05). PLC 
δ3, PLC δ1, and PLC γ2 all had significant effects on Ca2+i when compared to IVF and 
Sham injected controls (P>0.05) but was not different from the no sperm control group 
(P<0.05). Oocytes in treatments of PLC δ3, PLC δ1, and PLC γ2 that showed no Ca2+i 
were further treated with additional controls of Ionomycin and/or IP3 to confirm calcium 
release mechanisms were functional in these oocytes (Figure 3-2 and Table 3-2).
 
Impact of PLC Isotypes on Cleavage Rates
 Micro-injecting PLC β1, PLC β2, PLC β3, PLC β4, PLC ε, and PLC γ1 had no 
effect on cleavage rates when compared to IVF and Sham controls (P>0.05). PLC δ3, 
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PLC δ1, PLC η2, PLC δ4, and PLC γ2 all had significant effects on cleavage rates when 
compared to IVF and Sham injected controls (P<0.05). PLC δ3 was not different from no 
sperm control (P<0.05) (Figure 3-3 and Table 3-3).
 PLC η2 and PLC δ4 had no effect on Ca2+i but did have a significant impact on 
cleavage rates. It was hypothesized that they were involved in CICR and RyR 
functionality. To test this, PLC η2 and PLC δ4 isotypes were investigated in conjunction 
with known IP3R and RyR antagonists in a set of experiments. 
Impact of PLC η2 and PLC δ4 on CICR as Determined 
by Intracellular Calcium Transients
 Micro-injecting PLC η2 and PLC δ4 had no impact on Ca2+i following 6 hours of 
IVF (P>0.05). Micro-injecting the know IP3R antagonist heparin (HP), 6 h post 
fertilization, had a significant impact on Ca2+i when compared to IVF and sham controls 
(P<0.05). Similarly the known RyR antagonist procaine (PC) greatly effected Ca2+i when 
compared to IVF and sham controls (P<0.05). The combinations of PC/PLC δ4, PC/PLC 
η2, HP/PLC η2, and HP/PLC δ4 significantly decreased Ca2+i from IVF and showed no 
significant difference from the no sperm control group (Figure 3-4 and Table 3-4). 
Impact of PLC η2 and PLC δ4 on CICR as Determined by Cleavage Rates
 All treatments were significantly different from IVF and Sham control groups. 
Treatments IP3 + PLC η2/No Sperm, IP3 + PLC δ4/No Sperm, HP/PLC η2, and HP/PLC 
δ4 showed no difference from the No Sperm control group. The remaining groups of HP, 
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PC, PLC η2, PLC δ4, PC/PLC η2, and PC/PLC δ4 were statistically different from IVF, 
Sham and the No Sperm control groups (Figure 3-5 and Table 3-5).
Discussion
 A hallmark of oocyte activation is the rise of Ca2+i from internal stores. All models 
studied to date display Ca2+i at oocyte activation, but the specific pathway leading to this 
even differs between species. To better understand the pathway leading to bovine oocyte 
activation the present study was conducted to: 1) determine which PLC isotypes are 
present in bovine gametes, 2) determine the impact microinjecting antibodies against 
PLC isotypes will have on Ca2+i transients following IVF, 3) determine the impact 
microinjecting antibodies against PLC isotypes will have on cleavage rates 48 hourst post 
IVF.
PLC Isotypes in Bovine Oocytes and Spermatozoa
 Several PLC Isotypes have been reported to be present in spermatozoa. One study 
found δ4, β1, β3, and γ2 all present in mouse sperm and that δ4 was involved in the 
acrosome reaction and zona pellucida penetration [83]. Others have also reported that 
PLC γ [84], β1 [85], and ζ [86] are also present in mouse sperm and are either involved in 
the acrosome reaction and/or fertilization. PLC ζ has drawn much attention as the 
proposed mammalian SOAF [41, 86-89]. While others state that the epididymal and 
testicular expression profiles in mouse and human do not support its role as SOAF [90]. 
Mouse oocytes have been shown to have mRNA coding for β1, β3, and γ [91]. PLC γ1 
[91] and β1 [92] have also been detected by western blotting. 
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 Here we report the first evidence of endogenous PLC isotypes in bovine 
spermatozoa and oocytes.  Sperm were acrosome reacted, then lysed to represent the state 
at sperm-vittelline membrane binding and to eliminate any PLC isotypes that would be 
removed during the acrosome reaction. We determined that PLC δ1 and δ3 are present in 
both bovine oocytes and spermatozoa.  PLC δ4, γ2, and η2 were detected in bovine 
oocytes and ζ is present in sperm (Figure 3-1). The other PLC isotypes were not detected 
in either bovine oocytes or sperm (data not shown). Although PLC ζ is present in sperm, 
it did not impact bovine oocyte activation.
PLC Isotypes Involed in Bovine Oocyte Activation 
 From the combination of Ca2+i and cleavage rates we conclude that the PLC 
isotypes involved in bovine oocyte activation are δ1, δ3, δ4, γ2, and η2. PLC δ1, δ3, and 
γ2 significantly impact both Ca2+i and cleavage rates, leading to the conclusion that they 
are potentially involved in both IP3R and RyR activation.  The isotypes δ4 and η2 did not 
impact Ca2+i visualization and only impacted cleavage rates. Ca2+i was visualized 6 hours 
post fertilization, while cleavage rates were calculated 48 hours post fertilization. We 
hypothesized that δ4 and η2 are involved in CICR and the impact of the microinjected 
antibodies are not seen until after Ca2+i had been measured. To answer this hypothesis we 
used the known antagonist of IP3R, Heparin (HP) and the known antagonist of RyR, 
Procaine (PC), to track the effects of these PLC isotypes on CICR. It is accepted that 
Ca2+i can come from two cellular stores and by two separate channels [20, 93]. Both IP3R 
and RyR are involved in Ca2+i in many different cell types and have been shown to be 
involved in sea urchin oocyte activation [94]. IP3R and RyR are both present in murine 
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[21, 95, 96], porcine [97], humans [98-100], and bovine [19, 20] oocytes. IP3R is 
involved in the initial Ca2+i release seen at activation, while the RyR functions more with 
a CIDR mechanism [101]. Both IP3R and RyR appear to produce repetitive Ca2+i 
transients [102-104]. A control group of IP3 + δ4/No Sperm and IP3 + η2/No Sperm were 
included to validate functionality of IP3R and confirm that the PLC isotypes were not 
effecting Ca2+i release from IP3R. Ionomycin and IP3 controls were used to verify that 
the calcium-releasing machinery of the oocyte was functional. All treatments used 
significantly impacted Ca2+i transients (Figure 3-4 and Table 3-4). Cleavage rates were 
similary effected by the treatments, with HP + δ4 and HP + η2 showing no difference 
from the No Sperm control group.(Figure 3-5 and Table 3-5). The combination of Ca2+i 
and cleavage rates leads to the conclusion that both δ4 and η2 are involved in the 
propagation of Ca2+i transients and most likely function in a pathway involved with RyR 
activation. When IP3R was block with HP and either δ4 or η2 was present, cleavage rates 
dropped drastically, indicating that both mechanisms for Ca2+i release were inhibited. 
 It is well accepted in the literature that PLC ζ is involved in murine oocyte 
activation [41-44]. Here we report that unlike the murine model, PLC ζ is not required for 
bovine oocyte activation, further validating our hypothesis that the detailed pathway 
leading to mammalian oocyte activation differs among models.
 The process of ICSI alone is sufficient to activate human [66, 68], mice [69], 
hamster [46], and rabbits [48]. There is no need for membrane binding or an additional 
exogenous activation procedure with these species. This is not true for bovine. ICSI alone 
does not activate bovine oocytes [63, 71-77]. It appears that bovine oocytes are not 
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activated by a SOAF, require sperm-egg binding for oocyte activation, and involve PLC 
δ1, δ3, δ4, γ2, and η2 in pathways leading to IP3R and RyR Ca2+i transients. These PLC 
isotypes may function in a redundant manner or in tandem. A combination of Ca2+i and 
cleavage data leads to the hypothesis that PLC δ1, δ3, and γ2 may function in the early 
IP3R Ca2+i release. If this is sufficiently blocked, then Ca2+i visualization at 6 h post 
fertilization is significantly decreased (Figure 3-2 and Table 3-2). It is reasonable to 
conclude that if the initial Ca2+i is blocked that the later events of CICR would also be 
reduced. If CICR is hindered, MPF levels would remain elevated and evaluating cleavage 
rates at 48 h post fertilization would be decreased, as was seen (Figure 3-3 and Table 
3-3). 
 Previously reported results, along with the data reported here, reinforce the 
conclusion that mammalian species differ in the specific signal transduction pathways 
used at fertilization that lead to activation and induction of subsequent development. 
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Table 3-1.  Primary antibodies used for micro-injection and western blotting. All 
antibodies were purchased from Santa Cruz Biotechnology Inc.
PLC Antibody Target Epitope 
β1 G-12 sc-205 C-terminus
β2 Q-15 sc-206 C-terminus
β3 L-17 sc-31760 N-terminus
β4 C-18 sc-404 C-terminus
ε T-20 sc-28403 C-terminus
δ1 H-140 sc-30062 Amino acids 1-140 mapping at the N-terminus
δ3 L-15 sc-30826 Internal Region
δ4 Q-15 sc-30830 C-terminus
δ4 H-250 sc-30063 Amino acids 1-250 mapping at the N-terminus
γ1 E-12 sc-7290 Amino acids 1243-1262 near the C-terminus
γ2 B-10 sc-5283 Amino acids 826-985
η D-14 sc-104620 Internal Region
ζ C-12 sc-131752 C-terminus
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Table 3-2.  Effect of micro-injected antibodies on activation as determined by Ca2+i. a-d 
Unlike superscripts are significantly different (P < 0.05).
Treatment Number of Mature 
Oocytes
Number of Oocytes Showing 
Ca2+i (%)
Ionomycin 41 41 (100)a
IP3 30 27 (91.2)a,b
ε 30 22 (73.5)b,c
γ1 30 21 (70.6)b,c
δ4 40 27 (67.3)c
η2 30 20 (66.8)c
Sham 62 41 (66.1)c
β3 32 21 (65.7)c
IVF 239 155 (65.2)c
β1 31 20 (64.5)c
β2 30 19 (63.3)c
ζ 52 32 (63.0)c
β4 31 18 (58.2)c
δ3 50 16 (32.2)d
δ1 31 10 (32.1)d
γ2 56 11 (20.1)d
No Sperm 59 10 (16.9)d
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Table 3-3.  Effect of micro-injected antibodies on development as determined by rate of 
cleavage. a-c Unlike superscripts are significantly different (P < 0.05)
Treatment Number of Mature Oocytes Number of Cleaved Oocytes 
(%)
ζ
IVF
Sham
β3
β2
ε
β1
γ1
β4
δ1
δ4
γ2
η2
δ3
No Sperm
153 104 (66.8)a
973 659 (66.8)a
189 125 (66.7)a
96 63 (65.6)a
68 43 (62.7)a
79 49 (62.3)a
99 62 (61.3)a
72 44 (60.7)a
62 36 (57.9)a
133 43 (32.6)b
92 29 (31.7)b
125 39 (29.6)b
83 22 (26.0)b
79 19 (24.3)b,c
131 17 (12.8)c
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Table 3-4.  The effect of micro-injected antagonist, agonist, and antibodies on initial IP3R 
Ca2+i and RyR CICR of IVF produced embryos as determined by the rate of calcium 
transients. a-d Unlike superscripts are significantly different (P < 0.05).
Treatment Number of Mature 
Oocytes
Number of Oocytes Showing 
Ca2+i (%)
Ionomycin 41 41 (100)a
IP3 30 27 (91.2)a,b
IP3 + δ4 NO 
Sperm 13 11 (85.0)
a,b,c
IP3 + η2 NO 
Sperm 11 9 (83.3)
b,c
δ4 40 27 (67.3)c
η2 30 20 (66.8)c
Sham 62 41 (66.1)c
IVF 239 155 (65.2)c
Heparin 19 7 (36.5)d
Procaine + δ4 14 5 (35.0)d
Procaine 15 5 (32.8)d
Procaine + η2 13 4 (30.0)d
Heparin + η2 15 4 (26.1)d
Heparin + δ4 14 3 (21.7)d
No Sperm 59 10 (16.9)d
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Table 3-5.  The effect of micro-injected antagonist, agonist, and antibodies on initial IP3R 
Ca2+i and RyR CICR of IVF produced embryos as determined by the rate of cleavage. a-f 
Unlike superscripts are significantly different (P < 0.05).
Treatment Number of Mature Oocytes
Number of Cleaved Oocytes 
(%)
IVF 973 659 (66.8)a
Sham 189 125 (66.7)a
Heparin 51 21 (41.1)b
Procaine 54 21 (38.8)b,c
δ4 92 29 (31.7)b,c, 
Procaine + δ4 59 16 (28.1)b,c,d,e
Procaine + η2 46 12 (26.1)b,c,d,e
η2 83 22 (26.0)b,c,d,e
IP3+ η2 NO sperm 27 6 (21.8)b,c,d,e,f
IP3 + δ4 NO 
sperm 24 4 (16.7)
c,d,e,f
Heparin + η2 45 7 (15.5)d,e,f
Heparin + δ4 80 12 (15.4)e,f
No Sperm 131 17 (12.8)f
Table 3-5.  The effect of micro-injected antagonist, agonist, and antibodies on 
initial IP3R Ca2+i and RyR CICR of IVF produced embryos as determined by the 
rate of cleavage. a-f Unlike superscripts are significantly different (P < 0.05).
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Figure 3-1.  Western blots of PLC Isotypes in bovine oocytes, sperm, 
bovine control, and positive control lysates. 
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Figure 3-2.  The effect of micro-injected antibodies on oocyte activation of IVF 
produced embryos as determined by the rate of calcium transients. Error bars 
represent standard deviation within treatment group. a-d Unlike superscripts are 
significantly different (P < 0.05) IM (Ionomycin control) NS (No Sperm control)
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Figure 3-3.  The effect of micro-injected antibodies on development of IVF produced 
embryos as determined by the rate of cleavage. Error bars represent standard 
deviation within treatment group. a-c Unlike superscripts are significantly different (P 
< 0.05). NS (No Sperm control)
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Figure 3-4.  The effect of micro-injected antagonist, agonist, and antibodies on initial 
IP3R Ca2+i and RyR CICR of IVF produced embryos as determined by the rate of 
calcium transients. Error bars represent standard deviation within treatment group. a-d 
Unlike superscripts are significantly different (P < 0.05) IM (Ionomycin) PC 
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Figure 3-5.  The effect of micro-injected antagonist, agonist, and antibodies on initial 
IP3R Ca2+i and RyR CICR of IVF produced embryos as determined by the rate of 
cleavage. Error bars represent standard deviation within treatment. a-f Unlike 
superscripts are significantly different (P < 0.05) PC (Procaine), HP (Heparin), NS 
(No Sperm control) 
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CHAPTER 4
SUMMARY
 In addition to contributing genes at fertilization, the sperm cell induces the oocyte 
to leave its state of metabolic arrest through a process called activation. A hallmark of 
oocyte activation is a release of intracellular calcium (Ca2+i) from the endoplasmic 
reticulum stores that results in repetitive transients. The mediators of oocyte activation 
have been studied extensively in sea urchin, zebrafish, ascidian, starfish, Xenopus, and 
murine models. To date, little is known about the biochemical pathway in bovine oocyte 
activation. Global conclusions regarding mammalian are often attributed to work in the 
murine model. Caution must be used in making generalizations from one animal model to 
another. This research dissertation delineates and defines putative roles of Src Family 
Kinase (SFKs) and Phopholipase C (PLC) enzymes in the pathway leading to Ca2+i and 
calcium-induced calcium-release (CICR) in bovine oocyte activation and establishes 
specific differences among mammalian models. Based upon the results in these studies 
bovine and murine models follow different oocyte activation pathways.  
 A brief overview of activation pathways among all animal models indicates that 
both SFK and/or PLC enzymes are involved. SFK has been proposed to active PLC 
which cleaves phosphatidylinositol 4,5-bisphosphate (PIP2), producing membrane bound 
diacylglycerol, and cytosolic soluble 1,4,5-inositol trisphosphate (IP3). Cytosolic IP3 can 
then bind to IP3 receptors located on the membrane of the endoplasmic reticulum and 
initiate the release of stored calcium. The release of Ca2+ leads to a second source of 
calcium release, through CICR and ryanodine receptors (RYR). 
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 The first facet of the research reported in this dissertation was understanding the 
role SFKs play in bovine oocyte activation. The SFKs present in both bovine oocytes and 
spermatozoa are BLK, YES, SRC and FYN. LYN and HCK were detected in bovine 
spermatozoa.  Micro-injection of PP2, a known inhibitor of multiple members of SFK, 
was used to determine that one or more SFKs are involved in activation. An injection of 3 
µM PP2 abolished Ca2+i release and cleavage rates. This points to the involvement of one 
or more members of SFKs. Also, PP2 inhibits the activation of focal adhesion kinase 
(FAK), which associates with integrin receptor molecules found on the vitelline 
membrane. Integrin binding induces FAK activation and downstream signal transduction, 
specifically SFKs. Integrins are present in bovine oocytes and have been shown to play a 
role in their activation. Microinjection of SRC peptide non-phosphorylated (SRCnPp), a 
thirteen amino acid peptide mimics the C-terminal phosphoregulatory region of SRC, had 
no effect on Ca2+i release and cleavage rates. However, microinjection of a phophorylated 
version of this peptide (SRCPP) blocked signal transduction significantly. Based on these 
results, it was hypothesized that endogenous phosphatase removes the inhibitory 
phosphate from endogenous SRC at the phosphoregulatory residue, Tyr527, causing the 
SH2 domain to release from the C-terminal region. In this state, SH2 is free to bind to the 
microinjected SRCPP, and thus inhibits downstream signal relay.  The potential role of 
SFK was further validated by microinjection of a substrate of SRC, Src Substrate II 
(SSII). As SRC is activated, it further relays a signal to downstream substrates. The 
microinjected SSII acted to sequester any signal produced by endogenous SRC. These 
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data implicate SRC and potentially other members of SFKs in the process of bovine 
oocyte activation. 
 The second facet of this research focused on the involvement of PLC isotypes. 
PLC δ1 and δ3 are present in both bovine oocytes and spermatozoa.  PLC δ4, γ2, and η2 
are also present in bovine oocytes and ζ is present only in sperm. The PLC isotypes β1, 
β2, β3, β4, γ1, and ε were not detected in either bovine oocytes or sperm. Although PLC ζ 
is present in sperm, it did not appear to be involved in bovine oocyte activation, as 
determined by both Ca2+i release and cleavage rates.
 The PLC isotypes involved in bovine oocyte activation are δ1, δ3, δ4, γ2, and η2, 
as determined by both Ca2+i release and cleavage. The PLCs δ1, δ3, and γ2 significantly 
decreased both Ca2+i release and cleavage rate, while PLC δ4 and η2 only impacted 
cleavage. These results lead to a further investigation as to why δ4 and η2 only effected 
cleavage and their potential involvement with the specific Ca2+i RyR. The possible role of 
PLC δ4 and η2 seems to be in CICR and RyR induced release of Ca2+i. PLC δ1, δ3, and 
γ2 are involved in initial Ca2+i release through IP3R. Their involvement with RyR was 
not within the scope of this study. Further experiments would need to be designed to 
answer this question. 
 From a combination of the work carried out in this study and past work by other 
colleagues point to why a generalized conclusion regarding mammalian fertilization 
should not be made from one single animal species. Bovine oocyte activation differs from 
that reported in the murine and other animals. 
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 It appears that the biochemical signal transduction pathway in bovine oocyte 
activation is receptor mediated. It is likely that a disintegrin on the inner acrosomal 
membrane ligand of a spermatozoa binds to a integrin on the oocyte vitelline membrane, 
causing the clustering of FAK. This would recruit SRC, and potentially other SFKs, to the 
binding site. As SRC is activated, its affects work downstream to activate the PLCs δ1, 
δ3, and/or γ2, most likely in a redundant fashion to ensure successful signal transduction. 
These PLCs induce the cleavage of PIP2, producing DAG and IP3. IP3 then binds to 
IP3R located on the ER resulting in the release of Ca2+i. The presence of cytosolic Ca2+i 
activates RyR. Endogenous oocyte PLC δ4 and η2 interact with RyR to produce CICR 
and propagate Ca2+i over several hours, thus facilitating proper oocyte activation.
 Together these data provide significant information that establishes the 
involvement of SFK and PLC isotypes in bovine oocyte activation. Studies involving the 
selective SFK inhibitor PP2 target Src, Lck, and Fyn. Microinjecting PP2 had significant 
impacts on Ca2+i and cleavage rates, implicating one of PP2‘s targeted SFKs in bovine 
oocyte activation. To further study the involvement of Src in bovine oocyte activation, 
peptides mimicking the C-terminal region of Src were injected in both a phosphorylated 
and non-phosphorylated form. Microinjecting Src-peptide phosphorylated significantly 
decrease Ca2+i and cleavage rates, solidifying the involvement of Src in the pathway 
leading to bovine oocyte activation. By microinjecting primary antibodies raised against 
the PLC family of enzymes it was determined that δ1, δ3, and γ2 play a role in the release 
of Ca2+i and by blocking their function a significant decrease in Ca2+i was observed. 
Evaluating the impact of PLC antibodies on cleavage rate showed the involvement of δ1, 
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δ3, δ4, η2 and γ2. These data raised the question, why δ4 and η2 were involved in 
cleavage rates but not the preceding Ca2+i release.  Additional experiments postulate that 
δ4 and η2 are likely involved in CICR and RyR activation. These data increase the 
understanding of the pathway leading to bovine oocyte activation and further confirm that  
the detailed pathway differs from one animal models to another. 
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 Course: Live Animal and Carcass Evaluation
AWARDS
 College of Agriculture Graduate Teaching Instructor of the Year 2010
 College of Agriculture, Utah State University, Logan, UT
 Awarded to the top graduate teaching instructor among all 
 academic department with in the college. 
 Graduate Student Senate Travel Award, Graduate Student 2006-2009
 Senate, Utah State University, Logan, UT
 A financial award to graduate student who demonstrate 
 outstanding research findings. Funds used for travel to national 
 scientific meetings in San Antonio, TX, San Francisco, CA and
 San Diego, CA. 
 Graduate Student Senate Enhancement Award Fall 2006
 Graduate Student Senate, Utah State University, Logan, UT
 One of seventeen graduate students awarded a $4,000 scholarship.
 Awarded to graduate students who demonstrate outstanding
 achievements and contributions to both USU and their
 respective departments. 
PRESENTATIONS
 Poster Presentation, Annual meeting of the American  2009
 Society for Cell Biology, San Diego, CA
 Identifying Endogenous PLC Isoforms Involved in the Signal
 Transduction Pathway at Bovine Oocyte Activation. 
 Oral and Poster Presentations, Intermountain Graduate 2009
 Symposium, Logan, UT
 Identifying Endogenous PLC Isoforms Involved in the Signal
 Transduction Pathway at Bovine Oocyte Activation.
 Poster Presentation, Annual meeting of the American 2008
 Society for Cell Biology, San Francisco, CA
 Identifying Molecules Involved in the Signal Transduction
 Pathway at Bovine Oocyte Activation Using Activators and
 Inhibitors of Src Family Kinases.
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PRESENTATIONS (continued)
 Oral and Poster Presentations, Intermountain Graduate 2008
 Identifying Molecules Involved in the Signal Transduction
 Pathway at Bovine Oocyte Activation Using Activators and
 Inhibitors of Src Family Kinases.
 Poster Presentation, Society for the Study of Reproduction,  2007
 San Antonio, TX
 Purification of Bovine Sperm Membrane-Proteins Involved 
 In Sperm-Oocyte Interactions: Adhesion, Fusion, and Activation.
 Oral Presentation, Center for Integrated Biosystems Research 2007
 Student Presentation, Logan, UT
 Sperm Ligands Involved In Sperm-Oocyte Interaction and Oocyte
 Pathways Involved In Activation 
 Poster Presentation, Intermountain Graduate Symposium 2007
 Logan, UT
 Purification of Bovine Sperm Membrane-Proteins Involved In 
 Sperm-Oocyte Interactions: Adhesion, Fusion, and Activation
 Poster Presentation, Intermountain Graduate Symposium 2007
 Logan, UT
 Involvement of Tyrosine Kinases, Specifically SRC Family Kinase, 
 Focal Adhesion Kinase, and Agonist-Induced PLC In the Activation
 And Development of Bovine Oocytes. 
ACADEMIC SERVICE
 College of Agriculture Senator, Graduate Student Senate, Utah 2008-2009
 State University, Logan, UT
 Organized events to promote graduate student involvement, 
 served on several committees, and relayed senate information 
 to College of Agriculture graduate students. 
 Stipend Enhancement Award Commitee, Graduate Student Spring 2009
 Senate, Utah State University, Logan, UT
 Determined eligibility, contributions, achievements, and need 
 of applicants interested in receiving a $4,000 stipend 
 enhancement award.
 ADVS Departmental Representative, Graduate Student 2007-2008
 Senate, Utah State University, Logan, UT
 Relayed information from college senator to ADVS students. 
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SPECIAL TRAINING
 Laboratory Safety, Utah State University, Logan, UT 2006 & 2009
 Environmental Health & Safety Certificate of Training
 Protein Purification: Isolation & Characterization,  2006
 Center for Integrated Biosystems, Utah State University, 
 Logan, UT
 Artificial Insemination, Synchronization of Estrus 2005
 and Animal Set-up for Embryo Transfer, Hoffman A.I.
 Breeders, Logan, UT
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REFERENCES
 Dr. Ken White
 4815 Old Main Hill
 Department of Animal, Dairy, and Veterinary Science
 Logan, UT 84322
 Office: 435-797-2162
 ken.white@usu.edu 
 Dr. Tom Bunch
 4815 Old Main Hill
 Department of Animal, Dairy, and Veterinary Science
 Logan, UT 84322
 Office: 435-797-2148
 tom.bunch@usu.edu
 Brett Bowman M.S.
 4815 Old Main Hill
 Department of Animal, Dairy, and Veterinary Science
 Logan, UT 84322
 Office: 435-797-2141
 brett.bowman@usu.edu
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